Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)

Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)

Abstract Background Outcomes of therapeutic studies in diffuse cutaneous systemic sclerosis (dcSSc) have mainly been measured for specific organs, particularly the skin and lungs. A new composite response index in dcSSc (CRISS) has been developed for clinical trials. The goal of this study was to de...

Full description

Bibliographic Details
Main Authors: Boyang Zheng, Marie Hudson, Mianbo Wang, Murray Baron, for the Canadian Scleroderma Research Group
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Arthritis Research & Therapy
Subjects:
Systemic sclerosis
Scleroderma
Immunosuppression
Outcomes
CRISS
Online Access:http://link.springer.com/article/10.1186/s13075-020-02220-0

Internet

http://link.springer.com/article/10.1186/s13075-020-02220-0

Similar Items